OXAZEPAM | A072253 | ACTAVIS ELIZABETH LLC
Highest NADAC/Unit
$1.44
per ea
Lowest NADAC/Unit
$0.7219
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00228207310OXAZEPAM 30 MG CAPSULE | $1.44 | EA | Generic | — | 2026-10-21 |
| 62584081401OXAZEPAM 30 MG CAPSULE | $1.44 | EA | Generic | — | 2026-10-21 |
| 00228206910OXAZEPAM 15 MG CAPSULE | $0.8346 | EA | Generic | — | 2026-10-21 |
| 62584081301OXAZEPAM 15 MG CAPSULE | $0.8346 | EA | Generic | — | 2026-10-21 |
| 00228206710OXAZEPAM 10 MG CAPSULE | $0.7219 | EA | Generic | — | 2026-10-21 |
| 62584081201OXAZEPAM 10 MG CAPSULE | $0.7219 | EA | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.